Last reviewed · How we verify
Best available antiviral drug therapy
Best available antiviral drug therapy is a Small molecule drug developed by Cell Medica Ltd. It is currently in Phase 3 development for Viral infections (specific indication not publicly disclosed).
This antiviral therapy works by inhibiting viral replication through direct targeting of viral enzymes or proteins essential for the virus lifecycle.
This antiviral therapy works by inhibiting viral replication through direct targeting of viral enzymes or proteins essential for the virus lifecycle. Used for Viral infections (specific indication not publicly disclosed).
At a glance
| Generic name | Best available antiviral drug therapy |
|---|---|
| Sponsor | Cell Medica Ltd |
| Modality | Small molecule |
| Therapeutic area | Virology/Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
The drug functions as a broad-spectrum antiviral agent, likely targeting conserved viral protease or polymerase enzymes that are critical for viral replication and spread. By blocking these key viral processes, the therapy reduces viral load and allows the immune system to control the infection more effectively.
Approved indications
- Viral infections (specific indication not publicly disclosed)
Common side effects
Key clinical trials
- Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department (NA)
- The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation (PHASE2)
- Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 (NA)
- Alternate Donor Study of Pre-Emptive Cellular Therapy (PHASE2)
- Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Best available antiviral drug therapy CI brief — competitive landscape report
- Best available antiviral drug therapy updates RSS · CI watch RSS
- Cell Medica Ltd portfolio CI
Frequently asked questions about Best available antiviral drug therapy
What is Best available antiviral drug therapy?
How does Best available antiviral drug therapy work?
What is Best available antiviral drug therapy used for?
Who makes Best available antiviral drug therapy?
What development phase is Best available antiviral drug therapy in?
Related
- Manufacturer: Cell Medica Ltd — full pipeline
- Therapeutic area: All drugs in Virology/Infectious Disease
- Indication: Drugs for Viral infections (specific indication not publicly disclosed)